GenScript jumps on associate's cancer drug's $334 mln sales

Genscript Biotech

23/01/2025 03:51

** GenScript Biotech  1548.HK  jumps as much as 7.2% to
HK$10.98, highest since Dec. 11, 2024
    ** Stock set for biggest one-day pct rise since Oct. 22,
2024 and is on course for sixth consecutive session of gains
    ** Co's associate Legend Biotech  LEGN.O  announces its drug
CARVYKTI, used to treat cancer of the bone marrow, brought in
~$334 mln in net trade sales in quarter ended Dec. 31, 2024, up
from year-ago $159 mln
    ** GenScript fell 50.5% last year

 (Reporting by Donny Kwok)
 ((donny.kwok@thomsonreuters.com))